FDA: New suppliers to ease 2 cancer drug shortages

www.kimatv.com: : Federal regulators said Tuesday that they've approved new suppliers for two crucial cancer drugs, easing critical shortages - at least for the time being - that have patients worried about missing life-saving treatments.




3 people shared this quote till date.

Related Articles


  • Cancer Patients Struggle to Pay Rising Drug Costs

    mtmweb.biz
    Shared once

    The medical community is starting to think in terms of how treatment choices impacts a cancer patient's everyday life such as buying groceries...


  • Study identifies biomarkers that predict patients' response to certain colon cancer drugs

    www.news-medical.net
    Shared once

    The Stem Cells and Cancer Research Group headed by Dr H-ctor G. Palmer at the Vall d'Hebr-n Institute of Oncology (VHIO) has identified the molecular mechanisms that determine patients' response to certain drugs used in clinical trials for colon cancer treatment. The study led by VHIO also benefited from the collaboration with Professor Alberto Mu-oz-s laboratory at the Instituto de Investigaciones Biomedicas Alberto Sols, Consejo Superior de Investigaciones Cient-ficas.


  • Stem cell drug approved in Canada to treat bone marrow transplant symptoms

    www.globalpost.com
    Shared once

    Canadian regulators have approved the world's first stem cell drug. The drug, Prochymal, will be used to treat a deadly side effect of bone marrow transplants called acute graft-versus host disease, which occurs in children.


  • Discovery of mechanisms predicting response to new treatments in colon cancer

    www.eurekalert.org
    Shared once

    The Vall d'Hebron Institute of Oncology identifies biomarkers that predict resistance to treatment which will enable a better selection of patients who stand to benefit as well as avoid the administration of ineffective medicines. These findings identify experimental drugs to overcome resistance and open new therapeutic avenues in combinatorial treatment.


  • Canada OKs World's 1st Stem Cell Therapy - Prochymal may ease complication from bone marrow transplants

    www.newser.com
    Shared once

    Canada has approved the world's first stem cell treatment for a systemic disease, Reuters reports. This week, the nation's health regulators allowed doctors to use the drug Prochymal for children... Science News Summaries. | Newser


blog comments powered by Disqus